The Australia vaccines market was valued at $0.6 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 7.2% from 2024 to 2033.
The global newcastle disease vaccine market was valued at $0.4 billion in 2023, and is projected to reach $0.6 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.